Anne Gussow

Array ( [id] => 6326876 [patent_doc_number] => 20100197595 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => 'TREATMENT OF MELANOMA WITH ALPHA THYMOSIN PEPTIDES' [patent_app_type] => utility [patent_app_number] => 12/758714 [patent_app_country] => US [patent_app_date] => 2010-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 4787 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20100197595.pdf [firstpage_image] =>[orig_patent_app_number] => 12758714 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4596491 [patent_doc_number] => 07982024 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-19 [patent_title] => 'Antibodies to insulin-like growth factor I receptor' [patent_app_type] => utility [patent_app_number] => 12/756417 [patent_app_country] => US [patent_app_date] => 2010-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 29 [patent_no_of_words] => 36375 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/982/07982024.pdf [firstpage_image] =>[orig_patent_app_number] => 12756417 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6340053 [patent_doc_number] => 20100247545 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'ANTIBODIES TO M-CSF' [patent_app_type] => utility [patent_app_number] => 12/748602 [patent_app_country] => US [patent_app_date] => 2010-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 37472 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20100247545.pdf [firstpage_image] =>[orig_patent_app_number] => 12748602 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6503979 [patent_doc_number] => 20100260752 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-14 [patent_title] => 'OPSONIC AND PROTECTIVE ANTIBODIES SPECIFIC FOR LIPOTEICHOIC ACID OF GRAM POSITIVE BACTERIA' [patent_app_type] => utility [patent_app_number] => 12/691908 [patent_app_country] => US [patent_app_date] => 2010-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 35471 [patent_no_of_claims] => 102 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20100260752.pdf [firstpage_image] =>[orig_patent_app_number] => 12691908 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8629396 [patent_doc_number] => 08361465 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-29 [patent_title] => 'Use of anti-sphingosine-1-phosphate antibodies in combination with chemotherapeutic agents' [patent_app_type] => utility [patent_app_number] => 12/690033 [patent_app_country] => US [patent_app_date] => 2010-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 37117 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 298 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12690033 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6560246 [patent_doc_number] => 20100272640 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-28 [patent_title] => 'Monoclonal Antibodies Against PCBP-1 Antigens, and Uses Therefor' [patent_app_type] => utility [patent_app_number] => 12/684090 [patent_app_country] => US [patent_app_date] => 2010-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 16344 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20100272640.pdf [firstpage_image] =>[orig_patent_app_number] => 12684090 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6633191 [patent_doc_number] => 20100173428 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'Protein Phosphorylation By Basophillic Serine/Threonine Kinases' [patent_app_type] => utility [patent_app_number] => 12/683835 [patent_app_country] => US [patent_app_date] => 2010-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 32017 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20100173428.pdf [firstpage_image] =>[orig_patent_app_number] => 12683835 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6453268 [patent_doc_number] => 20100189649 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-29 [patent_title] => 'MONOCLONAL ANTIBODIES TO ACTIVATED ERBB FAMILY MEMBERS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 12/651527 [patent_app_country] => US [patent_app_date] => 2010-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 27874 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20100189649.pdf [firstpage_image] =>[orig_patent_app_number] => 12651527 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7510806 [patent_doc_number] => 20110256579 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'Method for Verifying and/or Identifying Hormonally Effective Substances' [patent_app_type] => utility [patent_app_number] => 13/141342 [patent_app_country] => US [patent_app_date] => 2009-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15619 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20110256579.pdf [firstpage_image] =>[orig_patent_app_number] => 13141342 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6581864 [patent_doc_number] => 20100291111 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'Use of Anti-Alpha5Beta1 Antibodies to Inhibit Cancer Cell Proliferation' [patent_app_type] => utility [patent_app_number] => 12/642687 [patent_app_country] => US [patent_app_date] => 2009-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16696 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20100291111.pdf [firstpage_image] =>[orig_patent_app_number] => 12642687 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8214620 [patent_doc_number] => 08193316 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-05 [patent_title] => 'TACI-Fc fusion proteins, methods of making and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/638392 [patent_app_country] => US [patent_app_date] => 2009-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10207 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/193/08193316.pdf [firstpage_image] =>[orig_patent_app_number] => 12638392 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6635067 [patent_doc_number] => 20100226854 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-09 [patent_title] => 'MHC Peptide Complexes and Uses Thereof in Infectious Diseases' [patent_app_type] => utility [patent_app_number] => 12/619039 [patent_app_country] => US [patent_app_date] => 2009-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 77 [patent_figures_cnt] => 77 [patent_no_of_words] => 225802 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20100226854.pdf [firstpage_image] =>[orig_patent_app_number] => 12619039 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7685454 [patent_doc_number] => 20100120687 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'Modulating apoptosis' [patent_app_type] => utility [patent_app_number] => 12/617639 [patent_app_country] => US [patent_app_date] => 2009-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 17113 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20100120687.pdf [firstpage_image] =>[orig_patent_app_number] => 12617639 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6320465 [patent_doc_number] => 20100196364 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => 'MONOCLONAL ANTIBODIES TO FIBROBLAST GROWTH FACTOR RECEPTOR 2' [patent_app_type] => utility [patent_app_number] => 12/614282 [patent_app_country] => US [patent_app_date] => 2009-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 12661 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20100196364.pdf [firstpage_image] =>[orig_patent_app_number] => 12614282 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6289872 [patent_doc_number] => 20100158904 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'TREATMENT WITH ANTI-ALPHA2 INTEGRIN ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/614178 [patent_app_country] => US [patent_app_date] => 2009-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 31147 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20100158904.pdf [firstpage_image] =>[orig_patent_app_number] => 12614178 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7967065 [patent_doc_number] => 07939639 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-10 [patent_title] => 'Functional role of adrenomedullin (AM) and the gene related product (PAMP) in human pathology and physiology' [patent_app_type] => utility [patent_app_number] => 12/569821 [patent_app_country] => US [patent_app_date] => 2009-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 76 [patent_no_of_words] => 20320 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/939/07939639.pdf [firstpage_image] =>[orig_patent_app_number] => 12569821 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6441554 [patent_doc_number] => 20100104574 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-29 [patent_title] => 'Frizzled-Binding Agents and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/568534 [patent_app_country] => US [patent_app_date] => 2009-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 57 [patent_figures_cnt] => 57 [patent_no_of_words] => 52560 [patent_no_of_claims] => 72 [patent_no_of_ind_claims] => 39 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20100104574.pdf [firstpage_image] =>[orig_patent_app_number] => 12568534 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6292583 [patent_doc_number] => 20100239581 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-23 [patent_title] => 'KIDNEY DISEASE TARGETS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/557303 [patent_app_country] => US [patent_app_date] => 2009-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42789 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20100239581.pdf [firstpage_image] =>[orig_patent_app_number] => 12557303 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6588757 [patent_doc_number] => 20100061993 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'Antibodies' [patent_app_type] => utility [patent_app_number] => 12/585180 [patent_app_country] => US [patent_app_date] => 2009-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 54608 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20100061993.pdf [firstpage_image] =>[orig_patent_app_number] => 12585180 [rel_patent_id] =>[rel_patent_doc_number] =>)